Single nucleotide polymorphisms that predict HCV treatment outcomes
摘要
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
申请公布号
EP2589670(A1)
申请公布日期
2013.05.08
申请号
EP20130152522
申请日期
2011.04.11
申请人
F. HOFFMANN-LA ROCHE AG
发明人
CHU, TOM;ESSIOUX, LAURENT;GERMER, SOREN;LOPATIN, URI;SHULMAN, NANCY;THOMMES, JAMES